Hedge Funds Trim Mag 7 Stakes Before SpaceX IPO
Key insights
- JPMorgan data shows the Roundhill Magnificent Seven ETF fell more than 2.4% since June 5 as hedge funds reduce tech exposure.
- Vanda Research tracked retail investors' longest net-selling streak since March 2020, with Monday outflows the heaviest since November 2023.
- SpaceX prices its IPO at $135 per share, targeting roughly $75 billion in proceeds at a $1.75 trillion valuation.
Why this matters
Capital rotation of this scale directly pressures the relative performance of AI-adjacent software stocks, which practitioners and technical founders track as proxies for sector health. SpaceX's $1.75 trillion IPO valuation sets a benchmark that will shape how institutional investors price the anticipated Anthropic and OpenAI public offerings expected later in 2026, influencing dilution expectations and secondary-market valuations across the AI ecosystem. The sustained institutional selling of software stocks signals that near-term capital allocation is shifting toward capital-intensive frontier ventures, compressing multiples for AI companies seeking near-term liquidity.
Summary
Hedge funds are reducing Magnificent Seven exposure ahead of SpaceX's Nasdaq debut. JPMorgan data shows the Roundhill Magnificent Seven ETF down more than 2.4% since June 5, with software stocks absorbing the heaviest selling.
Vanda Research logged a three-day retail net-selling streak through Wednesday, the longest since March 2020. Monday's outflows were the deepest since November 2023.
Essentially: (JPMorgan, Vanda Research) institutional and retail data both signal capital rotating into SpaceX, priced at $135 per share at a $1.75 trillion valuation.
- SpaceX posted a 2025 net loss of $4.94 billion on $18.67 billion in revenue
- Anthropic and OpenAI public offerings are expected later in 2026, likely extending the pressure
At $1.75 trillion, SpaceX would rank seventh among publicly traded U.S. companies by market cap.
Potential risks and opportunities
Risks
- Roundhill Magnificent Seven ETF holders face continued downside if Anthropic and OpenAI IPO timelines accelerate in 2026, sustaining capital outflows well past SpaceX's debut.
- SpaceX's 2025 net loss of $4.94 billion on $18.67 billion in revenue could disappoint post-IPO investors anchored to growth-only narratives, triggering a sell-off that reverses capital unpredictably back into existing tech names.
- Retail investors who exited Magnificent Seven positions to participate in SpaceX at $135 per share face concentrated single-stock exposure in a company entering public markets at a $1.75 trillion valuation with a recent net loss.
Opportunities
- Active managers who hold Magnificent Seven positions through the IPO-driven dip could benefit from mean-reversion buying once SpaceX capital deployment settles and outflow pressure eases.
- Investment banks advising on the anticipated Anthropic and OpenAI public offerings later in 2026 gain pricing leverage as demonstrated institutional appetite for frontier AI listings scales with SpaceX's success.
- Late-stage private investors in SpaceX holding shares below $135 are positioned for gains if public markets sustain the $1.75 trillion valuation, validating the pre-IPO capital rotation strategy for analogous bets on Anthropic and OpenAI.
What we don't know yet
- Whether hedge funds established net short positions or merely reduced long exposure is not clarified by the JPMorgan data cited in the article.
- Which individual Magnificent Seven companies saw the largest outflows is not specified, leaving it unclear whether AI-focused names drove the bulk of selling.
- Specific timing and deal structures for Anthropic and OpenAI public offerings remain unconfirmed beyond 'later in 2026,' making it impossible to model how long selling pressure will persist.
Originally reported by finance.yahoo.com
Read the original article →Original headline: Hedge Funds Cut Mag 7 Exposure and Go Short Ahead of SpaceX IPO — Retail Investors Log Longest Net-Selling Streak Since March 2020